Health ❯ Treatment

Therapeutics

Targeted Therapy Drug Development Neuroprotection Targeted Therapies Infectious Disease Treatment Protein Therapy Protein Manipulation PTSD Management Metabolic Pathways Antibodies Disease Prevention Drug Repurposing Neuroprotective Agents Amyloid-Beta Antibodies Cardiovascular Therapies Alzheimer's Treatment Inflammation Precision Medicine Molecular Pathways Targeted Treatments Molecular Targets Innovative Treatments Regenerative Medicine Inflammatory Pathways Novel Therapeutics Fibrosis Treatment Vaccines Supportive Care Vaccine Development Antiviral Drugs

Study Shows Epstein‑Barr Virus Provokes CD4+ T‑Cell Attack Linked to Multiple Sclerosis

The finding points to antivirals or vaccines that target active EBV as a possible way to prevent or treat MS without lifelong immune suppression.

Study Recasts Myelin Repair as Survival of Constantly Differentiating OPCs

Toxin-Producing Gut Bacterium Linked to Ulcerative Colitis in Science Report

Alzheimer’s Study Ties Familial SORL1 Variant to Fewer, Weaker Brain Exosomes

MIT-Led Cell Atlas Charts Epigenomic Breakdown in Alzheimer’s Progression

Early Smell Loss in Alzheimer’s Driven by Microglial Axon Removal

Thymosin β4 Reverses Early Alzheimer’s Defects in Organoids and Mouse Models

Scientists Broaden Search for Human Pegivirus in Parkinson’s Brains

Boosting Apolipoprotein M Shows Promise Against Age-Related Macular Degeneration

Mitochondrial Dysfunction Linked to Cerebellar Degeneration in Progressive Multiple Sclerosis